Antifungal Drugs Strategic Business Report 2024-2030: Trends in Prophylactic Use of Antifungal Drugs in High-Risk Populations Propel Market Growth - A US$22 Billion Market by 2030
September 17, 2024 07:51 ET
|
Research and Markets
Dublin, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The "Antifungal Drugs - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Antifungal Drugs was...
Outlook on the Cryptococcosis Treatment Global Market to 2026 - Drug Development and Evolving Clinical Trial Ecosystem Presents Opportunities
June 25, 2021 05:53 ET
|
Research and Markets
Dublin, June 25, 2021 (GLOBE NEWSWIRE) -- The "Global Cryptococcosis Treatment Market (2021-2026) byTreatment, Distribution Channel, Geography and the Impact of COVID-19 with Ansoff Analysis" report...
Worldwide Systemic Aspergillosis and Systemic Candidiasis Industry to 2027 - Increase in R&D Activities and Pipeline of New Drugs Presents Opportunities
March 16, 2021 07:43 ET
|
Research and Markets
Dublin, March 16, 2021 (GLOBE NEWSWIRE) -- The "Systemic Aspergillosis and Systemic Candidiasis Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type, and Geography" report has been...
Global Cryptococcosis Treatment Market 2020-2025 - Key Players are Glenmark Pharmaceuticals, Abbott Laboratories, Pfizer, Bristol-Mayers Squibb, Sigmapharm Laboratories, Novartis
October 23, 2020 05:48 ET
|
Research and Markets
Dublin, Oct. 23, 2020 (GLOBE NEWSWIRE) -- The "Global Cryptococcosis Treatment Market 2020-2025" report has been added to ResearchAndMarkets.com's offering. The Global Cryptococcosis Treatment...
Global Cryptococcosis Treatment Market Global Forecast to 2025: Increasing Availability of Generic and Over-the-Counter Medicine
September 17, 2020 06:13 ET
|
Research and Markets
Dublin, Sept. 17, 2020 (GLOBE NEWSWIRE) -- The "Cryptococcosis Treatment Market Research Report by Treatment (Amphotericin B, Fluconazole, and Flucytosine), by Distribution (Hospital Pharmacies,...